Most men diagnosed with prostate cancer have a nonaggressive form of the disease, with tumors that grow very slowly — so slowly that the men may never experience any cancer - related complications and die from other causes.
They found that of the 3,656
men diagnosed with prostate cancer who did not undergo aggressive treatment, only 166 men, or 4.5 percent, were being monitored appropriately, said Dr. Karim Chamie, the study's first author and an assistant professor of urology at UCLA.
UNC Lineberger researchers led by Ronald C. Chen surveyed 1,171
men diagnosed with prostate cancer in North Carolina, finding that while both white and black men were concerned about curing their cancer and the quality - of - life impacts of treatment, more black men considered other social and personal factors — such as recovery time and cost — to be very important in their treatment decision - making.
Dr Matthew Hobbs, Deputy Director of Research at Prostate Cancer UK said, «To greatly improve the survival chances of the 47,000
men diagnosed with prostate cancer each year, it's clear that we need to move away from the current one - size - fits - all approach to much more targeted treatment methods.
Of the nearly 200,000
men diagnosed with prostate cancer each year in the United States, radiation is a first - line therapy considered for all but the most advanced disease.
«We are hopeful that the hard work that went into the development of these much - needed guidelines will pay off in improved care for the approximately 240,000
men diagnosed with prostate cancer every year,» said Rebecca Cowens - Alvarado, MPH, principal investigator for the National Cancer Survivorship Resource Center, director of Cancer Control Mission Strategy at the American Cancer Society and co-author of the report.
The majority of
men diagnosed with prostate cancer have low risk disease and face a difficult decision between having the disease managed conservatively through AS or undergoing definitive therapy.
«Since the difference in the number of
men diagnosed with prostate cancer is related to how many men undergo PSA testing, we think our data shows that PSA testing and early treatment is related to a modest decrease in risk of prostate cancer death,» says Håkan Jonsson statistician and senior author of the study.
Men diagnosed with prostate cancer can be provided with a more accurate estimate of their risk of death from the disease, and treatment planned accordingly, according to a Research Article published by Vincent J. Gnanapragasam, of the University of Cambridge, Cambridge, UK and colleagues in PLOS Medicine.
834
men diagnosed with prostate cancer were studies and found that those with the highest blood levels of omega - 3 fatty acids saw a 43 % increased risk of developing cancer when compared to the men with the lowest omega - 3 fatty acid concentration (65).
The study included 47 911
men diagnosed with prostate cancer and 642 of these had a fatal prostate cancer.
Prolaris provides personalized information for
men diagnosed with prostate cancer to help assist in determining the best possible treatment plan.
Prolaris provides personalized information for
men diagnosed with prostate cancer to help assist in determining the best possible treatment plan.
Prolaris provides personalized information for
men diagnosed with prostate cancer to help assist in determining the best possible treatment plan.